Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q7M7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009059 | macromolecule biosynthetic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0018130 | heterocycle biosynthetic process | 4 | 2 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 2 |
GO:0032774 | RNA biosynthetic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.634 |
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.642 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.466 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.501 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.652 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.576 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.490 |
CLV_PCSK_PC7_1 | 169 | 175 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.721 |
CLV_PCSK_SKI1_1 | 427 | 431 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 501 | 505 | PF00082 | 0.598 |
CLV_PCSK_SKI1_1 | 579 | 583 | PF00082 | 0.375 |
DEG_APCC_DBOX_1 | 578 | 586 | PF00400 | 0.378 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.788 |
DOC_CDC14_PxL_1 | 349 | 357 | PF14671 | 0.341 |
DOC_MAPK_gen_1 | 598 | 606 | PF00069 | 0.277 |
DOC_MAPK_MEF2A_6 | 257 | 266 | PF00069 | 0.476 |
DOC_PP4_FxxP_1 | 197 | 200 | PF00568 | 0.450 |
DOC_SPAK_OSR1_1 | 161 | 165 | PF12202 | 0.463 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.400 |
DOC_USP7_MATH_1 | 436 | 440 | PF00917 | 0.503 |
DOC_USP7_MATH_1 | 491 | 495 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 508 | 512 | PF00917 | 0.634 |
DOC_USP7_MATH_1 | 638 | 642 | PF00917 | 0.568 |
DOC_USP7_UBL2_3 | 149 | 153 | PF12436 | 0.433 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.393 |
DOC_WW_Pin1_4 | 233 | 238 | PF00397 | 0.376 |
DOC_WW_Pin1_4 | 504 | 509 | PF00397 | 0.546 |
DOC_WW_Pin1_4 | 574 | 579 | PF00397 | 0.514 |
DOC_WW_Pin1_4 | 623 | 628 | PF00397 | 0.589 |
LIG_14-3-3_CanoR_1 | 126 | 130 | PF00244 | 0.643 |
LIG_14-3-3_CanoR_1 | 16 | 22 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 368 | 375 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 392 | 398 | PF00244 | 0.521 |
LIG_14-3-3_CanoR_1 | 4 | 9 | PF00244 | 0.710 |
LIG_14-3-3_CanoR_1 | 471 | 477 | PF00244 | 0.389 |
LIG_14-3-3_CanoR_1 | 543 | 547 | PF00244 | 0.534 |
LIG_14-3-3_CanoR_1 | 579 | 588 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 598 | 606 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 84 | 89 | PF00244 | 0.561 |
LIG_Actin_WH2_2 | 558 | 573 | PF00022 | 0.460 |
LIG_BRCT_BRCA1_1 | 532 | 536 | PF00533 | 0.417 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.438 |
LIG_FHA_1 | 368 | 374 | PF00498 | 0.409 |
LIG_FHA_1 | 401 | 407 | PF00498 | 0.507 |
LIG_FHA_1 | 476 | 482 | PF00498 | 0.457 |
LIG_FHA_1 | 581 | 587 | PF00498 | 0.411 |
LIG_FHA_2 | 173 | 179 | PF00498 | 0.483 |
LIG_FHA_2 | 516 | 522 | PF00498 | 0.698 |
LIG_FHA_2 | 536 | 542 | PF00498 | 0.491 |
LIG_FHA_2 | 562 | 568 | PF00498 | 0.521 |
LIG_IRF3_LxIS_1 | 539 | 545 | PF10401 | 0.344 |
LIG_LIR_Apic_2 | 196 | 200 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 207 | 217 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 460 | 464 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 533 | 539 | PF02991 | 0.389 |
LIG_MYND_1 | 623 | 627 | PF01753 | 0.360 |
LIG_PCNA_PIPBox_1 | 283 | 292 | PF02747 | 0.434 |
LIG_PCNA_yPIPBox_3 | 241 | 249 | PF02747 | 0.412 |
LIG_PCNA_yPIPBox_3 | 359 | 368 | PF02747 | 0.392 |
LIG_SH2_CRK | 18 | 22 | PF00017 | 0.624 |
LIG_SH2_GRB2like | 109 | 112 | PF00017 | 0.714 |
LIG_SH2_GRB2like | 81 | 84 | PF00017 | 0.779 |
LIG_SH2_GRB2like | 88 | 91 | PF00017 | 0.721 |
LIG_SH2_NCK_1 | 435 | 439 | PF00017 | 0.427 |
LIG_SH2_SRC | 435 | 438 | PF00017 | 0.530 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.676 |
LIG_SH2_STAP1 | 18 | 22 | PF00017 | 0.643 |
LIG_SH2_STAP1 | 532 | 536 | PF00017 | 0.384 |
LIG_SH2_STAT3 | 137 | 140 | PF00017 | 0.574 |
LIG_SH2_STAT3 | 57 | 60 | PF00017 | 0.637 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.650 |
LIG_SH3_2 | 499 | 504 | PF14604 | 0.569 |
LIG_SH3_3 | 392 | 398 | PF00018 | 0.518 |
LIG_SH3_3 | 438 | 444 | PF00018 | 0.434 |
LIG_SH3_3 | 494 | 500 | PF00018 | 0.533 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.575 |
LIG_SUMO_SIM_anti_2 | 186 | 191 | PF11976 | 0.419 |
LIG_SUMO_SIM_anti_2 | 263 | 269 | PF11976 | 0.345 |
LIG_SUMO_SIM_anti_2 | 344 | 350 | PF11976 | 0.350 |
LIG_SUMO_SIM_anti_2 | 485 | 491 | PF11976 | 0.446 |
LIG_TRAF2_1 | 405 | 408 | PF00917 | 0.488 |
LIG_TRAF2_1 | 446 | 449 | PF00917 | 0.423 |
LIG_TRAF2_1 | 507 | 510 | PF00917 | 0.585 |
LIG_UBA3_1 | 145 | 153 | PF00899 | 0.405 |
LIG_UBA3_1 | 413 | 419 | PF00899 | 0.473 |
LIG_UBA3_1 | 472 | 480 | PF00899 | 0.415 |
LIG_WRC_WIRS_1 | 458 | 463 | PF05994 | 0.566 |
LIG_WW_3 | 498 | 502 | PF00397 | 0.480 |
MOD_CDK_SPK_2 | 574 | 579 | PF00069 | 0.494 |
MOD_CK1_1 | 313 | 319 | PF00069 | 0.605 |
MOD_CK1_1 | 396 | 402 | PF00069 | 0.529 |
MOD_CK1_1 | 475 | 481 | PF00069 | 0.450 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.426 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.407 |
MOD_CK2_1 | 285 | 291 | PF00069 | 0.477 |
MOD_CK2_1 | 436 | 442 | PF00069 | 0.451 |
MOD_CK2_1 | 504 | 510 | PF00069 | 0.543 |
MOD_CK2_1 | 515 | 521 | PF00069 | 0.695 |
MOD_CK2_1 | 535 | 541 | PF00069 | 0.497 |
MOD_CK2_1 | 561 | 567 | PF00069 | 0.494 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.712 |
MOD_GlcNHglycan | 385 | 388 | PF01048 | 0.406 |
MOD_GlcNHglycan | 420 | 423 | PF01048 | 0.457 |
MOD_GlcNHglycan | 427 | 430 | PF01048 | 0.351 |
MOD_GlcNHglycan | 444 | 447 | PF01048 | 0.377 |
MOD_GlcNHglycan | 482 | 485 | PF01048 | 0.447 |
MOD_GlcNHglycan | 642 | 645 | PF01048 | 0.540 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.437 |
MOD_GSK3_1 | 396 | 403 | PF00069 | 0.567 |
MOD_GSK3_1 | 504 | 511 | PF00069 | 0.497 |
MOD_GSK3_1 | 515 | 522 | PF00069 | 0.750 |
MOD_N-GLC_1 | 491 | 496 | PF02516 | 0.429 |
MOD_N-GLC_1 | 598 | 603 | PF02516 | 0.449 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.550 |
MOD_NEK2_1 | 172 | 177 | PF00069 | 0.453 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.489 |
MOD_NEK2_1 | 472 | 477 | PF00069 | 0.439 |
MOD_NEK2_1 | 561 | 566 | PF00069 | 0.406 |
MOD_NEK2_1 | 633 | 638 | PF00069 | 0.442 |
MOD_PIKK_1 | 136 | 142 | PF00454 | 0.580 |
MOD_PIKK_1 | 178 | 184 | PF00454 | 0.426 |
MOD_PIKK_1 | 355 | 361 | PF00454 | 0.422 |
MOD_PIKK_1 | 475 | 481 | PF00454 | 0.425 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.635 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.529 |
MOD_PKA_2 | 367 | 373 | PF00069 | 0.460 |
MOD_PKA_2 | 542 | 548 | PF00069 | 0.536 |
MOD_PKB_1 | 14 | 22 | PF00069 | 0.559 |
MOD_PKB_1 | 72 | 80 | PF00069 | 0.648 |
MOD_Plk_1 | 183 | 189 | PF00069 | 0.385 |
MOD_Plk_1 | 491 | 497 | PF00069 | 0.471 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.772 |
MOD_Plk_2-3 | 515 | 521 | PF00069 | 0.480 |
MOD_Plk_4 | 17 | 23 | PF00069 | 0.592 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.475 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.429 |
MOD_Plk_4 | 485 | 491 | PF00069 | 0.342 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.387 |
MOD_ProDKin_1 | 233 | 239 | PF00069 | 0.380 |
MOD_ProDKin_1 | 504 | 510 | PF00069 | 0.549 |
MOD_ProDKin_1 | 574 | 580 | PF00069 | 0.508 |
MOD_ProDKin_1 | 623 | 629 | PF00069 | 0.579 |
MOD_SUMO_for_1 | 201 | 204 | PF00179 | 0.465 |
MOD_SUMO_rev_2 | 236 | 243 | PF00179 | 0.388 |
TRG_DiLeu_BaEn_1 | 167 | 172 | PF01217 | 0.464 |
TRG_DiLeu_BaEn_1 | 344 | 349 | PF01217 | 0.346 |
TRG_DiLeu_BaEn_4 | 277 | 283 | PF01217 | 0.414 |
TRG_DiLeu_BaLyEn_6 | 141 | 146 | PF01217 | 0.391 |
TRG_DiLeu_LyEn_5 | 167 | 172 | PF01217 | 0.517 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.624 |
TRG_ER_diArg_1 | 13 | 16 | PF00400 | 0.679 |
TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.718 |
TRG_ER_diArg_1 | 169 | 171 | PF00400 | 0.444 |
TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.451 |
TRG_NES_CRM1_1 | 258 | 272 | PF08389 | 0.406 |
TRG_Pf-PMV_PEXEL_1 | 563 | 567 | PF00026 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I169 | Leptomonas seymouri | 43% | 98% |
A0A0S4JB89 | Bodo saltans | 23% | 88% |
A0A1X0P251 | Trypanosomatidae | 39% | 100% |
A0A3S7X349 | Leishmania donovani | 92% | 97% |
A0A422P4U2 | Trypanosoma rangeli | 38% | 100% |
A4HI33 | Leishmania braziliensis | 78% | 94% |
A4I5A9 | Leishmania infantum | 92% | 97% |
C9ZQP3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 88% |
E9B0K5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 97% |